ReShape Lifesciences (RSLS) Insider Trading & Ownership $6.25 +0.24 (+3.99%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ReShape Lifesciences (NASDAQ:RSLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.01%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$26,448.00Number OfInsiders Selling(Last 3 Years)2 Get RSLS Insider Trade Alerts Want to know when executives and insiders are buying or selling ReShape Lifesciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RSLS Insider Buying and Selling by Quarter ReShape Lifesciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/25/2023Thomas StankovichCFOSell0$391.50$0.00 10/11/2023Thomas StankovichCFOSell0$1,348.50$0.00 9/1/2023Thomas StankovichCFOSell0$1,290.50$0.00 8/24/2023Thomas StankovichCFOSell0$2,059.00$0.00 8/4/2023Thomas StankovichCFOSell0$2,073.50$0.00 7/6/2023Thomas StankovichCFOSell0$2,131.50$0.00 6/30/2023Thomas StankovichCFOBuy12$2,204.00$26,448.00 5/31/2023Thomas StankovichCFOSell0$3,494.50$0.00 4/30/2023Thomas StankovichCFOSell0$3,422.00$0.00 3/31/2023Thomas StankovichCFOSell0$3,770.00$0.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/28/2023Thomas StankovichCFOSell0$6,162.50$0.00 2/2/2023Thomas StankovichCFOSell0$19,270.50$0.00 1/24/2023Thomas StankovichCFOSell0$10,860.50$0.00 11/4/2022Thomas StankovichCFOSell0$19,575.00$0.00 10/4/2022Thomas StankovichCFOSell0$20,300.00$0.00 9/6/2022Thomas StankovichCFOSell0$28,275.00$0.00 8/5/2022Barton P BandyCEOSell0$34,075.00$0.00 8/5/2022Thomas StankovichCFOSell0$34,075.00$0.00 7/1/2022Barton P BandyCEOSell0$39,875.00$0.00 7/1/2022Thomas StankovichCFOSell0$39,875.00$0.00 6/1/2022Barton P BandyCEOSell0$68,875.00$0.00 5/31/2022Thomas StankovichCFOBuy0$66,700.00$0.00 (Data available from 1/1/2013 forward) RSLS Insider Trading Activity - Frequently Asked Questions Who is on ReShape Lifesciences's Insider Roster? The list of insiders at ReShape Lifesciences includes Barton P Bandy, and Thomas Stankovich. Learn more on insiders at RSLS. What percentage of ReShape Lifesciences stock is owned by insiders? 0.01% of ReShape Lifesciences stock is owned by insiders. Learn more on RSLS's insider holdings. Which ReShape Lifesciences insiders have been buying company stock? The following insider purchased RSLS shares in the last 24 months: Thomas Stankovich ($26,448.00). How much insider buying is happening at ReShape Lifesciences? Insiders have purchased a total of 12 RSLS shares in the last 24 months for a total of $26,448.00 bought. Which ReShape Lifesciences insiders have been selling company stock? The following insider sold RSLS shares in the last 24 months: Thomas Stankovich ($0.00). How much insider selling is happening at ReShape Lifesciences? Insiders have sold a total of 0 ReShape Lifesciences shares in the last 24 months for a total of $0.00 sold. ReShape Lifesciences Key ExecutivesMr. Dan W. Gladney (Age 71)Executive Chair Compensation: $129.5kMr. Paul F. Hickey (Age 59)CEO, President & Director Compensation: $506.42kMr. Thomas Stankovich (Age 63)Senior VP & CFO Compensation: $307.12kDr. Mark B. Knudson Ph.D. (Age 75)Co-Founder and Special Advisor to the CEO Compensation: $33kDr. Katherine S. Tweden Ph.D. (Age 63)Co-Founder Compensation: $338.41kMr. Al DiazVice President of Operations and R&DDr. Dov Gal D.V.M.M.B.A., VP of Regulatory Clinical Quality & Compliance OfficerJody B. DahlmanDirector of CommunicationsMr. Naqeeb A. Ansari (Age 63)Senior Vice President of Global Commercial Operations Compensation: $327.46k More Insider Trading Tools from MarketBeat Related Companies Abbott Laboratories Insider Transactions Intuitive Surgical Insider Transactions Boston Scientific Insider Transactions Stryker Insider Transactions Medtronic Insider Transactions Becton, Dickinson and Company Insider Transactions Edwards Lifesciences Insider Transactions IDEXX Laboratories Insider Transactions ResMed Insider Transactions DexCom Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NASDAQ:RSLS) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RSLS Stock Free RSLS Stock Alerts